alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 89, Number 11 (Wednesday, January 17, 2024)]
[Notices]
[Pages 2967-2968]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00774]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which

[[Page 2968]]

would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; HHS-NIH-CDC-SBIR PHS 2024-1 Phase 
I: Adjuvant Development for Vaccines for Infectious and Immune-
Mediated Diseases (Topic 128).
    Date: February 8-9, 2024.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G22, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Michael M. Opata, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G22, 
Rockville, MD 20852, 240-627-3319, <a href="/cdn-cgi/l/email-protection#98f5f1fbf0f9fdf4b6f7e8f9ecf9d8f6f1f0b6fff7ee"><span class="__cf_email__" data-cfemail="9bf6f2f8f3fafef7b5f4ebfaeffadbf5f2f3b5fcf4ed">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: January 11, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-00774 Filed 1-16-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
From: "Hill, Donna B." <DBHILL@southernco.com> 

 

 To: Josh Hall/DC/USEPA/US@EPA 

 Cc: Ronald Jordan/DC/USEPA/US@EPA 

 Date: 09/04/2009 05:09 PM 

 Subject: Sample Selection for Methods Development Study 

Josh,

Attached are the sample selection criteria that we have used to select

FGD treated effluent samples for methods optimization and CRM

development studies. It is difficult to provide plant names because the

characteristics of the treated effluent can change for a given plant

over time. Our approach has been to collect several candidate samples

(more than what you need) and analyze them for TDS, calcium, sulfate,

chloride, magnesium, and sodium. These constituents are responsible for

most of the analytical interferences. If time allows, the samples

should also be analyzed for the metals of interest to get an idea of

their concentrations. Then, with the samples volumes already in hand,

you can select which samples are best for the study using the criteria

provided. EPRI used this approach for their DRC methods optimization

study and UWAG has recently used this approach for the CRM development

stabilization study.

Another approach would be for us to provide you with plant names based

on historical data. I would need extra time to contact the plants and

ask them if they would be willing to provide samples for your study.

Again, because the characteristics of the effluent can change over time,

I would recommend collecting more samples than you need for the study,

analyze them as discussed above, and then select which samples to use in

the study. If you want to take this approach, I would need at least 3

days to call the facilities.

If you would like to discuss, please let me know what time you can be

available on Tuesday. I am willing to help you as much as I can. I

think it is very good that EPA wants to pursue this methods optimization

work.

Thanks,

Donna

Donna B. Hill

Southern Co. Services

Research & Environmental Affairs

600 North 18th Street, Bin 14N-8195

Birmingham, AL 35203
Tel 205-257-5234

Cel 205-587-4846

Fax 205-257-7294

(See attached file: FGD WW Sample Selection Criteria.doc)
Exhibit 10.5

 

ENERKEM INC.
 (the “Company”)

 

AMENDMENT #1 TO THE EMPLOYEE STOCK OPTION PLAN

 

WHEREAS the Company adopted an Employee Stock Option Plan with effect on or about December 31, 2007 (the “Plan”) for employees, contractors, consultants, directors and officers of the Company and its Affiliates;

 

WHEREAS Section 3 of the Plan permits the board of directors of the Company (the “Board”) to amend the Plan at any time in order to increase the maximum number of shares reserved for issuance;

 

NOW, THEREFORE:

 

1.                                       Capitalized terms used but not otherwise defined herein have the meanings ascribed to such terms in the Plan.

 

2.                                       Section 3 of the Plan (Shares Reserved for Issuance) is amended to increase the maximum number of Shares reserved for issuance under the Plan from 61,078 to 324,535.

 

On and after the effective date hereof, any reference to “the Plan” in the Plan and any reference to the Plan in any other agreements will mean the Plan, as amended by this amendment. Except as specifically amended by this amendment, the provisions of the Plan remain in full force and effect.

 

Approved by a resolution of the Board dated January 27, 2010, with effect as of January 20, 2010.
I, Jaren Chan, CEO, certify that:



1. I have reviewed this quarterly report on Form 10-Q of Myoffiz, Inc.;



2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;



3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;



4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:



a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to us by others within the Corporation, particularly during the period in which this quarterly report is being prepared;



b) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and



c) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and



5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):



a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and



b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.





|September 30, 2004 | /s/    Jaren Chan      
|------------------ | -----------------------
|                   | Jaren Chan             
|                   | Chief Executive Officer
NOT FINAL UNTIL TIME EXPIRES TO FILE REHEARING

MOTION AND, IF FILED, DETERMINED

IN THE DISTRICT COURT OF APPEAL

OF FLORIDA

SECOND DISTRICT

MICHAEL WHITE, )

)

Appellant, )

)

v. ) Case Nos. 2D16-2294

) 2D16-2326

STATE OF FLORIDA, )

) CONSOLIDATED

Appellee. )

)

Opinion filed April 18, 2018.

Appeal from the Circuit Court for Lee 

County; Bruce E. Kyle, Judge.

Howard L. Dimmig, II, Public Defender and 

John C. Fisher, Assistant Public Defender, 

Bartow, for Appellant.

Pamela Jo Bondi, Attorney General, 

Tallahassee, and Jeffrey H. Siegal, 

Assistant Attorney General, Tampa, 

for Appellee.

PER CURIAM.

Affirmed. 

KHOUZAM, LUCAS, and SALARIO, JJ., Concur.
Unitil Corporation - Compensation of Directors



 Exhibit 10.23 

 
 UNITIL CORPORATION 

 
 Compensation of Directors 

 
 On January 17, 2012, the Board of Directors of Unitil Corporation
(“Unitil”) approved and adopted a revised compensation arrangement for members of the Board of Directors. The revised compensation arrangement became effective as of January 1, 2012. 

 
 The revised compensation arrangement applies to members of the Board of
Directors who are not employees of Unitil or any of its subsidiaries. The following table summarizes the material terms of the revised compensation arrangement. 
  


					
	 Category
	  	 Description
	  	 Amount

			
	 Board of Directors –

Annual Cash Retainer
	  	Each member of the Board of Directors will receive an annual cash retainer. Unitil will pay one-fourth of the annual cash retainer on the first business day of each fiscal
quarter.	  	$45,000 per year
			
	 Board of Directors –

Annual Equity Retainer
	  	Each member of the Board of Directors will receive an annual equity retainer. Unitil will issue the equity retainer on the first business day of October each year. In 2011, the
equity retainer was issued in the form of Unitil’s common stock. Beginning in 2012, each member may elect to receive restricted stock units (with any phantom dividends reinvested in additional restricted stock units), in lieu of Unitil’s
common stock, as his or her annual equity retainer.	  	$30,000 per year (payable in kind as common stock or restricted stock units)
			
	 Board of Directors –

Special Meetings
	  	Each member of the Board of Directors will receive a fee for each special meeting of the Board of Directors that such member attends in person.	  	$2,000 per special meeting
			
	 Committees –

Annual Cash Retainer for Chair
	  	Each chair of a committee of the Board of Directors will receive an annual cash retainer. Unitil will pay one-fourth of the annual cash retainer on the first business day of each
fiscal quarter.	  	$8,000 per committee per year
			
	 Committees –

Annual Cash Retainer for Non-Chair Members
	  	Each non-chair member of a committee of the Board of Directors will receive an annual cash retainer. Unitil will pay one-fourth of the annual cash retainer on the first business day
of each fiscal quarter.	  	$3,000 per committee per year

  
 In addition, Unitil will reimburse each
member of the Board of Directors for reasonable expenses that such member incurs in connection with attending meetings of the Board of Directors or committees thereof.
|   | (1) | The      Report fully complies with the requirements of Section 13(a) or 15(d) of      the Securities Exchange Act of 1934;and |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | The      information contained in the Report fairly presents, in all material      respects, the financial condition and results of operations of the      Company. |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| /s/ ROBERT      F. MANGANO  |                                       |
|---------------------------------------|--------------------------------------------|
| Name:                                 | Robert      F. Mangano                     |   |
| Title:                           | President      and Chief Executive Officer |   |
| Date:                                 | May      14, 2009                          |   |

| /s/ JOSEPH      M. REARDON  |                           |
|---------------------------------------|--------------------------------|
| Name:                                 | Joseph      M. Reardon         |   |
| Title:                           | Senior      Vice President and |   |
|                                  | Treasurer                      |   |
| Date:                                 | May      14, 2009              |   |

----
Exhibit 99.3

                            CERTIFICATION PURSUANT TO
                 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned hereby certifies, in accordance with 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his
capacity as an officer of Emmis Operating Company (the "Company"), that, to his
knowledge:

(1)      the Quarterly Report of the Company on Form 10-Q for the period ended
         November 30, 2002, fully complies with the requirements of Section
         13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)      the information contained in such report fairly presents, in all
         material respects, the financial condition and results of operations of
         the Company.

Dated:  January 14, 2003


                                            /s/ JEFFREY H. SMULYAN
                                            Jeffrey H. Smulyan
                                            Chairman of the Board, President and
                                            Chief Executive Officer
Exhibit 99.1



                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


     In connection  with this amended Annual Report of  UnionBanCal  Corporation
(the  "Company") on Form 10-K/A for the period ending December 31, 2002 as filed
with the Securities and Exchange  Commission on the date hereof (the  "Report"),
I, Norimichi Kanari, Chief Executive Officer of the Company,  certify,  pursuant
to  18  U.S.C.  Section  1350,  as  adopted  pursuant  to  Section  906  of  the
Sarbanes-Oxley Act of 2002, that, to my knowledge:

     (1) The Report fully  complies  with the  requirements  of Section 13(a) or
         15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
Company.



Dated:  July 10, 2003
      -------------------



                             By:    /s/ NORIMICHI KANARI
                                ---------------------------------
                                        Norimichi Kanari
                                    Chief Executive Officer
<PAGE>   1

                                                                 EXHIBIT 23.1

                       CONSENT OF INDEPENDENT ACCOUNTANTS


We hereby consent to the incorporation by reference in this Registration
Statement on Form S-8 of Nellcor Puritan Bennett Incorporated of our report
dated July 31, 1996 which appears on page 47 of the 1996 Annual Report to
Shareholders of Nellcor Puritan Bennett Incorporated, which is incorporated by
reference in the Nellcor Puritan Bennett Incorporated Annual Report on Form
10-K for the year ended July 7, 1996. We also consent to the incorporation by
reference in the Registration Statement on Form S-8 of our report dated July
23, 1996 appearing on page 1 of the Annual Report of the Nellcor Puritan
Bennett Voluntary Investment Plus (VIP) Plan on Form 11-K for the year ended
December 31, 1995.



PRICE WATERHOUSE LLP

San Jose, California
November 26, 1996
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                          74,564
<SECURITIES>                                         0
<RECEIVABLES>                                    1,026
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                81,559
<PP&E>                                          73,813
<DEPRECIATION>                                  23,294
<TOTAL-ASSETS>                                 370,703
<CURRENT-LIABILITIES>                           11,514
<BONDS>                                        281,266
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            11
<OTHER-SE>                                      72,218
<TOTAL-LIABILITY-AND-EQUITY>                   370,703
<SALES>                                         26,920
<TOTAL-REVENUES>                                26,920
<CGS>                                                0
<TOTAL-COSTS>                                   57,683
<OTHER-EXPENSES>                                   705
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              31,995
<INCOME-PRETAX>                               (57,994)
<INCOME-TAX>                                   (5,429)
<INCOME-CONTINUING>                           (52,565)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (52,565)
<EPS-PRIMARY>                                   (4.94)
<EPS-DILUTED>                                   (4.94)


</TABLE>
IN THE SUPREME COURT OF PENNSYLVANIA

WESTERN DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

RAFAEL GARY,

Petitioner :

:

:

:

:

:

:

:

:

:

: No. 35 WAL 2020

Petition for Allowance of Appeal

from the Order of the Superior Court

ORDER

PER CURIAM

AND NOW , this 27th day of May, 2020

, the Petition for Allowance of Appeal is

DENIED

.
EXHIBIT
          32.1
 CERTIFICATION
          PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF
          THE
          SARBANES-OXLEY ACT OF 2002
   The
          undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted
          pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that this Quarterly
          Report on Form 10 QSB for the period ended June 30, 2007 fully complies
          with the
          requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
          1934,
          as amended, and the information contained in such report fairly presents,
          in all
          material respects, the financial condition and results of operations of
          the
          Company.
 
 This
          16th
          day of August, 2007.


/s/
              Stephen D. Barnhill, M.D.Stephen
              D. Barnhill, M.D.Chief
                Executive Officer and Chairman
##### 



Exhibit 99.1
 A lliance B ancshares  C alifornia
 For Immediate Release
 Contacts:
    
    Daniel L. Erickson
    
    Cindy S. WaltersExecutive Vice President
    
    Senior Vice PresidentChief Financial Officer
    
    Director of Marketing(310) 258-9302
    
    (949) 223-4910
 Alliance Bancshares California Chairman Reis
Announces Predictions at Annual Shareholders Meeting
  th nd th rd




---



##### 



1.
    
    With a continuing squeeze of margins and a flat yield curve, expect earnings to
rise at least 15%.2.
    
    Total assets will rise from $876 million to over $1.05 billion or at least 20%.3.
    
    The economy of Southern California will slow down over the next year with real
estate prices lower than today.4.
    
    The Prime Rate will decline at least 50 basis points to 7.75% or less.5.
    
    The US economy will slow down with unemployment up somewhat.
 www.allbank.com
 cwalters@allbank.com
## COURT OF APPEALS

SECOND DISTRICT OF TEXAS

FORT WORTH

NO. 02

- 10

- 00 294

- CR

MIRANDA LOUISE MCPHE RSON APPELLANT

V.

THE STATE OF TEXAS STATE

------------

FROM THE 432 ND DISTRICT COURT OF TARRANT COUNTY

------------



### MEMORANDUM OPINION 1 

### AND JUDGMENT

----------

We have considered appellant’s A Withdrawal Of Notice Of Appeal Pursuant

To Texas Rule Of Appellate Procedure 42.2(a)

. @ The motion complies with rule

42.2(a) of the rules of appellate procedure. Tex. R. App. P. 42.2(a). No decision

of this court having been delivered before we received this motion, we grant the

motion and dismiss the appeal. See Tex. R. App. P. 42.2(a), 43.2(f).

PER CURIAM

PANEL: GARDNER, WALKER, and M C C OY, JJ.

DO NOT PUBLISH

Tex. R. App

. P

. 47.2(b)

DELIVERED: September 9 , 2010

1 See Tex. R. App. P. 47.4.
II

Calendar No. 536

104TH CONGRESS

2D SESSION S. 1566

To authorize the Secretary of Transportation to issue a certificate of documentation with appropriate endorsement for employment in the coastwise

trade for the vessel MARSH GRASS TOO.

IN THE SENATE OF THE UNITED STATES

FEBRUARY 7, 1996

Mr. HOLLINGS introduced the following bill; which was read twice and

referred to the Committee on Commerce, Science, and Transportation

JULY 26, 1996

Reported by Mr. PRESSLER, without amendment

A BILL

To authorize the Secretary of Transportation to issue a

certificate of documentation with appropriate endorsement for employment in the coastwise trade for the vessel

MARSH GRASS TOO.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 That notwithstanding sections 12106, 12107, and 12108

4 of title 46, United States Code, and section 27 of the Mer5 chant Marine Act, 1920 (46 U.S.C. App. 883), as applica-
2

•S 1566 RS

1 ble on the date of enactment of this Act, the Secretary

2 of Transportation may issue a certificate of documentation

3 with appropriate endorsement for employment in the

4 coastwise trade for the vessel MARSH GRASS TOO, hull

5 identification number AUKEV 51139K690.

Calendar No. 536

104TH CONGRESS

2D SESSION S. 1566

A BILL

To authorize the Secretary of Transportation to

wise trade for the vessel MARSH GRASS TOO.priate endorsement for employment in the coastissue a certificate of documentation with approJULY 26, 1996

Reported without amendment
Exhibit23.1

 

 

 

CONSENTOF INDEPENDENT ACCOUNTANTS

 

 

 

Weconsent to the incorporation by reference in the two Registration Statements onForm S-8 for the “Successories, Inc. Amended and Restated Stock Option Plan”filed with the Securities and Exchange Commission on January 9, 2002 andthe “Successories, Inc. Employee Stock Purchase Plan” filed with the Securitiesand Exchange Commission on January 20, 1999, of our report datedApril 2, 2003, except for Note 7 as to which the date is April 25,2003, appearing in this Annual Report on Form 10-K of Successories, Inc. andSubsidiaries for the years ended February 1, 2003, February 2, 2002, andFebruary 3, 2001.

 

 

 

Crowe Chizek and Company LLC

 

Oak Brook, Illinois

May 1, 2003

 

 

----